Document Detail

p53: guardian of reprogramming.
MedLine Citation:
PMID:  20948296     Owner:  NLM     Status:  In-Process    
The reprogramming of somatic cells to induced pluripotent stem (iPS) cells is one of the major discoveries of recent years. The development and application of patient specific iPS lines could potentially revolutionise cell-based therapy, facilitating the treatment of a wide range of diseases. Despite the numerous technological advancements in the field, an in-depth mechanistical understanding of the pathways involved in reprogramming is still lacking. Several groups have recently provided a mechanistical insight into the role of the p53 tumour suppressor pathway in reprogramming. The repercussions of these findings are profound and reveal an unexpected role of p53 as a "guardian of reprogramming", ensuring genomic integrity during reprogramming at the cost of a reduced efficiency of the process. Here we analyse the latest findings in the field and discuss their relevance for future applications of iPS cell technology.
Sergio Menendez; Suzanne Camus; Juan Carlos Izpisua Belmonte
Related Documents :
20948296 - P53: guardian of reprogramming.
7761396 - A dominant-negative mutant of human poly(adp-ribose) polymerase affects cell recovery, ...
20472336 - Curcumin causes superoxide anion production and p53-independent apoptosis in human colo...
21444956 - Cell death induced by the application of alternating magnetic fields to nanoparticle-lo...
10911726 - A ruthenium probe for cell viability measurement using flow cytometry, confocal microsc...
18024096 - Compound profiling for abcc2 (mrp2) using a fluorescent microplate assay system.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-10-09
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  9     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-10-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  3887-91     Citation Subset:  IM    
Center for Regenerative Medicine Barcelona, Barcelona, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Differential basal levels of MDM-2 transcription induced by p53-P72 and p53-R72.
Next Document:  G proteins as regulators in ethylene-mediated hypoxia signaling.